Premium Reports
 Download Report Brief  Download Full Report    Zoom in charts

Preferences

   Bookmark

Related Series

Healthcare IT Investor Update 2020 Q1
|
2020
Healthcare IT Investor Update 2019 Q4
|
2019
Healthcare IT Investor Update 2019 Q2
|
2019
Healthcare IT Investor Update 2018 Q4
|
2018
Healthcare IT Investor Update 2018 Q3
|
2018
Healthcare IT Investor Update 2018 Q2
|
2018
Healthcare IT Investor Update 2018 Q1
|
2018
Healthcare IT Investor Update 2017 Q4
|
2017
Healthcare IT Investor Update 2017 Q3
|
2017
Healthcare IT Investor Update 2017 Q2
|
2017
Healthcare IT Investor Update 2017 Q1
|
2017

Related Blogs

 End chart zoom
Healthcare IT Investor Update 2019 Q3 Healthcare IT Investor Update 2019 Q3
* A page refresh may be necessary to see the updated image

Healthcare IT Investor Update 2019 Q3

author - Aaron Gleave
Author
Aaron Gleave
author - Sam Eaquinto
Author
Sam Eaquinto
 
July 12, 2019

Current Time Inside Cache Tag Helper: 10/26/2021 11:54:21 PM and Model.reportId = 1572

In the 2019 Q3 Investor Update, KLAS investment experts Chris Chandler and Ben Brown discuss market share data for the healthcare business intelligence, along with the impact of recent acquisitions in this pace, EHR satisfaction and the athenahealth purchase, and KLAS Decision Insights data. Find out how these high energy topics will impact the investing landscape moving forward.

HtmlReportContent Current Time Inside Cache Tag Helper: 10/26/2021 11:54:21 PM and Model.reportId= 1572 and Model.HtmlReportContent_LastWriteTimeUtcInTicks=637406508670086394
 Download Report Brief  Download Full Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2021 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.